Regulation of T-cell survival is a physiological process involved in determining the immune response development, and also the expansion of T-cell tumours. Glucocorticoid hormones (GCH) have been implicated as regulators of Tlymphocyte growth and differentiation. In particular, GCH which by themselves are apoptosis activators and induce Tcell death, can also counteract apoptosis activated by other stimuli, for example antigen-TCR interaction. A number of biochemical events constitute different GCH-activated deathtriggering pathways and transcription activity regulation, either upstream and/or downstream in the pathways, is essential to apoptosis. Similarly, GCH-mediated inhibition of apoptosis also requires gene transcription regulation. In particular, between a number of GCH-induced genes, GITR and GILZ can inhibit apoptosis through interaction with mechanisms involved in T-cell survival regulation including the NF-kB transcription activity and the expression of the Fas/ FasL system. These observations indicate that this GCHactivated dual effect, induction and/or inhibition of T-cell death, requires transcription regulation.
Introduction
Glucocorticoid hormones (GCH) are commonly used as therapeutic agents for many acute and chronic inflammatory and auto-immune diseases, in transplant patients, and in the treatment of leukemias and lymphomas. 1 ± 5 The therapeutic action of these compounds has largely been attributed to their anti-inflammatory and immunosuppressive efficacy and to their growth arrest and death inducing activity. Most of their effects are due to the interaction wfith cytoplasm glucocorticoid receptors (GR) and modulation of gene transcription by direct GR/DNA interaction or by DNA-binding independent mechanisms which may involve protein to protein interactions. 1 ± 3,6,7 These effects comprise either up-regulation of expression of some molecules, such as lipocortin-1 (LIP-1) and a number of cytokine receptors, or transcription inhibition of others such as nitric oxide synthase (NOS), tachykinin NK1 receptor, a number of cytokines (NK) and some adhesion molecules. 2,8 ± 10 An important aspect of the GCH activity is the interaction with the immune system and in particular the effect directed on T-lymphocytes, whose growth, differentiation and redistribution can be influenced.
The T-cell response: the role of apoptotic selection
The immune T-cell compartment maintains the capability to respond to a wide variety of antigens (Ag). This capability is also due to the maintaining of living naõ Ève and memory T cells that express different T-cell receptors (TCR). The pool of selfmajor histocompatibility complex (MHC)-restricted TCRab+ Tlymphocytes is generated during T-cell development in the thymus by a positive selection process, whereas negative selection through apoptosis, ensures that the immune system is self-tolerant. 11 Selected cells are exported in the periphery as single positive (SP) lymphocyte, and continuous MHC recognition is required for the persistence of CD4 and selection becomes active again when an Ag/T-cell interaction occurs. In particular, some activated T cells survive (positive selection) the Ag/TCR-interaction, initiate cell cycle progression and proliferation to constitute the immune response, while many others die (negative selection) after activation (activation-induced cell death, AICD). These events are transcription-dependent, contribute to change the repertoire during life and induce the accumulation of memory cells which survive the Ag/TCR interaction. 12, 13 All this process involves the co-ordinated expression of a great number of genes, including those coding for cytokines and their receptors, such as for example IL-2, IFNg, TNFa and the Fas/FasL system. 14 ± 17 A number of genes, coding for transcription factors, have also been proposed to be involved in the selection process either to maintain resting T cells surviving, this is the case of LKLF transcription factor, 18 or contributing as regulators of specific T cell activation and death, such as for example AP-1, NFAT, NFkB, P53 and cAMP response element binding proteins (CREB). In addition, other genes including those of the bcl-2 and caspases families, contribute to regulate lymphocyte deletion and/or survival. 19, 20 All the above molecules and transcription factors should be expressed in a co-ordinated manner so that an organism maintains the capability to develop an immune response against viral and bacterial antigens, also in adults when thymus atrophy occurs, to return to normal levels of reactivity when the immune response is not longer requested for host defence, and autoimmunity could occur due to an excessive response. Moreover, long-surviving memory cells are maintained after Ag elimination.
Ag-induced apoptosis, a transcription-dependent event, plays an important role in the deletion of`unwanted' T cells in two phases in the ontogeny of the immune response. 21 ± 23 First, in the thymus, immunological tolerance to self-antigens can be acquired through negative selection of autoreactive T cells. Second, in the periphery, Ag-stimulation of the TCR/ CD3 complex leads to activation or anergy, and also to apoptosis (programmed cell death, PCD). In particular, it has been reported that the apoptosis of peripheral activated T cells, induced after activation by Ag such as Staphylococcus enterotoxin B (SEB) or immobilised anti-CD3 monoclonal antibodies (mAbs), occurs through a Fas/Fas-L-mediated autocrine suicide.
± 26
The role of coaccessory molecules in T-cell apoptosis Signals, other than Ag/TCR interaction, are involved in regulating T-cell death. In particular, coaccessory molecules, including CD4, CD28, CD44, CD2, and cytokines such as IL-2, IL-4 and IL-9, may be involved in regulating Tcell apoptosis. 27 ± 33 GCH regulators are also critical regulators of T-cell apoptosis in that they simultaneously activate a cell suicide and an anti-death program that also may contribute to determine susceptibility or resistance of cells. 34 ± 37 In particular, dexamethasone (DEX)7, a synthetic GCH specific for GR, induced cell death has been described in hybridoma T cells as well as in normal T cells, including thymocytes, peripheral lymphocytes (lymph node and spleen) and allospecific cytotoxic T lymphocytes (CTL). Moreover, mutual exclusion between two apoptosis inducers, namely anti-CD3 mAbs and DEX, has also been described in a T-cell hybridoma and normal T cells, indicating that GCH can also counter cell death and contribute to T cell survival. 37 ± 40 This binary effect, PCD activation and inhibition, is not surprising and it has been reported that GCH activate the caspases cascade, a central mechanism involved in T-cell apoptosis, and inhibit NF-kB, a transcription factor complex important in cell survival, but also weaken the activation-induced transcription increase of Fas and FasL, that play an important role in the triggering of AICD. 36, 39, 41 GCH and induction of T-cell apoptosis GCH can induce apoptosis in various cells including human osteoclast and osteoblast precursors, epithelial cells, eosinophils and lymphocytes.
34 ± 37,42 ± 44 A number of different, and in some cases cross-interacting, mechanisms are responsible for this effect ( Figure 1 ).
Since the original observation by Wyllie, it is well known that GCH induce death of both rodents and human thymocytes, and of more differentiated T cells in vitro and in vivo. This effect requires dimerization of the GR and direct binding to DNA GCH response element (GRE) 2, 6, 45, 46 and contribute to the anti-leukemia effect, to thymus atrophy and, at least in part, to the declining of T-cell number in the peripheral blood that follows GCH administration.
It has been shown that GCH-induced PCD is associated with Ca 2+ influx and/or mobilisation and activation of endonucleases, and is partially independent from a cytochrome-C/Apaf-1-linked pathway. 42, 43, 46 However, recent results suggest that DEX can induce mitochondria permeability transition, which then results in cytochrome-C release and activation of PCD. 47 Moreover, an increase of phosphatidylinositol-specific phospholipase C (PI-PLC) activity is required which precedes sequential acidic sphingomyelinase activation (aSMase), early ceramide production, caspases cascade activation (including caspases 3 and 6) 48 ± 50 and gene transcription. These results are in agreement with previous observations indicating that ceramide may contribute to caspases activation. 51 Interestingly enough, it has been recently reported that neutral sphingomyelinase (nSMase) activation and ceramide production also regulates IL-2 gene transcription and cell death. 52 Although transcription inhibitors do not interfere with the upstream signal pathway (PI-PLC, ceramide and caspases), induction of gene transcription is necessary in order that cell death occurs and transcription inhibitors completely prevent GCH-induced thymocytes apoptosis. 51, 53 This observation, indicating that protein synthesis is required after caspases activation, suggests that caspases may be necessary but not sufficient for cell death induction. In addition it could be hypothesised that caspases activation not only precedes but is also involved in the transcription regulation which then is responsible for cell death. In fact, in agreement with this hypothesis, it has recently been reported that caspase-3 can regulate the activity of NF-kB, a transcription factor involved in the regulation of apoptosis. 54 Moreover, this complex signal pathway is only activated following the GCH/GR interaction so that it is completely inhibited by GR antagonists, suggesting that non-transcription and transcription events are activated by GCH/GR interaction and constitute a sequential transduction pathway that runs from PI-PLC activation to gene transcription, which then activates apoptosis ( Figure 1) . A number of DEX-induced transcripts have been described to associate with PCD in immature thymocytes. 55 More recently, a cDNA has been described that codes for a Ca 2+ -binding protein and is a component of the GCH-triggered cell death. 56 However, the possible apoptotic role of newly activated genes remains a matter of debate and requires further studies aimed to define the specific role of each induced gene in the regulation of T-cell survival.
Other molecular mechanisms can play a role in the GCHinduced apoptosis. In fact, GCH are able to inhibit prostaglandin (PG) synthesis, through up-regulation of LIP-1 and down-modulation of phospholipase A 2 (PLA 2 ) genes transcription, 9 and nitric oxide (NO) generation, 2 through inhibition of inducible nitric oxide synthase (iNOS) gene transcription. Moreover, both NOS and iNOS have been described in thymocytes, normal T lymphocytes and a number of T-cell lines, 57 ± 61 and it has been reported that both PGs and NO modulate cell survival by either inducing or inhibiting lymphocyte PCD.
62 ± 66 GCH, through transcription regulation, could induce apoptosis in those systems where PGs and/or NO are required for cell survival (Figure 1) .
Similarly, GCH-mediated activity inhibition of the NF-kB transcription factor, either directly or by I-kB up-regulation, 67, 68 can contribute to cell death regulation. In fact, it has been shown that NF-kB acts as a survival factor in many cell systems. 69, 70 GCH-induced inhibition of NF-kB transcription activity could contribute to apoptosis induction in those cells where NF-kB/DNA binding is required for survival. 68 All the above mentioned GCH-activated pathways, the result of a number of different molecular events, require transcription activity regulation.
GCH and inhibition of T-cell apoptosis
GCH can induce a transcription-dependent inhibition of PCD in different cell types, including fibroblasts, epithelial cells and lymphocytes. 37, 38, 71 In particular, it has been suggested that the DEX-induced inhibition of TCR-activated death is Figure 1 Possible sequential signalling events in DEX-induced apoptosis. After DEX/GR interaction a number of molecular events constitute different deathtriggering pathways. In particular, DEX-induced activation of caspases 3 and 6 has been proposed. 48 ± 50 Inhibition of NO and/or PGs production results in an apoptosis induction when either NO or PGs protect from cell death. Loss of protection can also be induced by NF-kB activity inhibition. Transcription activity regulation, either RNA or protein synthesis, is upstream and/or downstream in the pathways. Note that other mechanisms, which do not appear in the figure, are possible attributable to the transcription inhibition of the Fas/FasL complex expression. 39 More recently, two DEX-induced genes, able to inhibit the Ag/TCR-activated apoptosis, have been described. In particular, it has been reported that overexpression of one of those genes, named GILZ, inhibits the activation-induced expression of Fas and FasL (see below). These observations suggest that the effect of a single agent on cell death or survival is unpredictable, when a complex of signals and stimuli interact in the same tissue, and that the GCH-induced inhibition of apoptosis depends on transcription regulation. The Ag/TCR interaction itself can result either in the positive (survival) or negative (apoptosis) selection of T cells, and other co-signals, including those delivered by coaccessory molecules CK and GCH, can favour one or the other event.
In particular, in vivo administration of DEX counters the lymph nodes CD4 + and CD8 + T lymphocyte death activated by SEB administration. 40 Moreover, GR lacking mice have altered thymocytes death and defective T cell in the periphery, indicating that GCH do play a role in the regulation of in vivo physiological process of T-cell death and selection. 72 
GITR: a new receptor of the tumor necrosis factor/ nerve growth factor receptor (TNF/NGFR) family
To study the role of glucocorticoid hormones in the regulation of lymphocyte apoptosis, we attempted the identification of genes activated by treatment with DEX in T cells. Comparing the cDNAs from untreated and DEX-treated cells, we identified some cDNAs only detectable in the treated cells. One of them, GITR (GITR, for: Glucocorticoid-Induced TNFR family-Related gene), displayed an increased expression detectable in T cells following DEX due to regulation at the transcription level. 73 Moreover, the gene expression is also induced by stimulation of the TCR complex, suggesting that GITR could play a role in T-cell activation. GITR is characterised by three cysteine pseudorepeats and displays significant homologies with members of the TNF/NGFR family. 73 ± 76 Despite the presence of common cysteine rich motifs in the extracellular domains, molecules of the TNF/NGFR family have different cytoplasm domains. The GITR cytoplasm domain has a striking homology with the cytoplasm domains of murine and human 4-1BB, CD27 and OX40, but does not show significant homology with that of other members of the TNF/NGFR family. 73, 75, 76 The similarity of the intracellular domain defines a new intracellular motif which could distinctivly identify a subfamily of the TNF/NGFR family, including GITR, 4-1BB, CD27 and OX40, from the one characterised by the death domain.
Transfection of selected hybridoma T-cell clones, that do not spontaneously express detectable GITR, confers resistance to TCR/CD3-induced apoptosis. Clones overexpressing GITR show some resistance to anti-CD3 mAbinduced apoptosis. However, modulation of GITR expression does not modify sensitivity to apoptosis stimuli different than TCR triggering such as irradiation, starvation and Fas-triggering. Moreover, in preliminary experiments a slight increase to DEX-induced apoptosis has been observed. These data suggest that GITR can modulate lymphocyte death and also that the effect, either protective or predisposing to apoptosis, is dependent on the apoptosis stimulus and/or cell activation.
The increase of GITR expression, following T-cell activation, suggests that this gene could modulate T lymphocyte AICD. Thus, T-lymphocyte activation could result in the induction of expression of molecules of the TNF/NGFR family, which can either activate or inhibit apoptosis. The balance between activating and inhibiting signals may represent a complex network involved in the control of T-cell survival and immune response progression. In this respect the data on the anti-apoptosis effect of GITR should be considered with caution, since it has been previously shown that a variety of agents and stimuli (including T-cell activation via Ag/TCR interaction) can either induce or inhibit apoptosis, depending on the experimental system adopted. 77, 78 These observations have implications for the evolution and function of the TNF/NGFR family, as well as for the mechanism of control of apoptosis in T-cells, and further suggest that GCH can activate transcription of genes able to regulate T-cell death (either induce or inhibit it) depending from the stage of T-cell activation and/or differentiation and the concomitant presence of other stimuli.
GITR and signal transduction pathway
The homology of GITR cytoplasm domain with other members of the TNF/NGFR family members such as 41BB, CD27 and OX40, opens the problem of signal transduction. 79 ± 81 In particular, like CD27, a coaccessory molecule previously described to either induce or inhibit apoptosis, 82, 83 GITR can bind Siva, a pro-apoptotic protein characterised by a peculiar death-domain able to activate apoptosis. 83 In fact, CD27 provides not only co-stimulatory signals able to protect lymphocytes and stimulate the immune response, but also induce cell death, and this can be explained on the base of Siva interaction. 82, 83 Like CD27, GITR binds Siva, so that might also induce apoptosis (Figure 2) , which is in keeping with the well known capability of GCH to either induce or inhibit apoptosis.
GILZ, a new leucine zipper family gene, regulates AICD
We also identified a new gene overexpressed in DEX-treated cells that we named GILZ (Glucocorticoid-Induced Leucine Zipper gene). 84 The protein putatively encoded by the GILZ mRNA is a leucine zipper protein of 137 aa with significant homologies with other molecules belonging to the leucinezipper family 85 ± 89 , as indicated by the presence of four leucine residues at positions 76, 83, 90 and 97 and one asparagine at position 87. Furthermore, a PAR region, rich in proline and acidic residues, is present at the 3' end region. GILZ is detectable in the nucleus of transfected clones, suggesting that like other leucine zipper molecules it might be involved in transcription regulation.
GILZ is expressed in normal T cells and this constitutive expression was clearly increased by treatment with DEX and inhibited by TCR-triggering in fresh thymocytes and T lymphocytes from peripheral lymphoid tissues, including spleen and lymph nodes.
We tested the possible effects of GILZ expression on Tcell apoptosis. The results obtained with transfected hybridoma T cells that do not express detectable GILZ, showed that cell clones overexpressing GILZ were variably resistant to anti-CD3 mAb-induced apoptosis when compared to control clones. On the contrary, GILZ overexpression did not counter apoptosis induced by DEX, various doses of UV irradiation, starvation or triggering by crosslinked anti-Fas mAb. These results suggest that GILZ gene can modulate apoptosis of hybridoma T-cell clones induced by treatment with anti-CD3 mAb and that could contribute in part to the DEXinduced inhibition of TCR/CD3-activated apoptosis. 36, 39, 72 It has been suggested that AICD is also dependent on Fas/FasL interaction. 24 ± 26 Thus, we performed experiments to assess whether the inhibition of apoptosis in GILZ-transfected cells could be mediated by an effect on Fas/FasL system expression. Results show that TCR complex activation by anti-CD3 mAb treatment, induced augmentation of Fas and induction of FasL expression in clones transfected by the empty vector, but did not augment Fas and FasL expression in T-cell clones overexpressing GILZ. These date indicate that GILZmediated inhibition of anti-CD3-induced apoptosis is the result, at least in part, of the inhibition of Fas and FasL mRNA expression and further confirms previous observations showing that DEX can inhibit FasL expression, thus regulating AICD. 39 ± 41 In fact, GILZ could interact either with signal(s) induced by TCR/CD3 triggering in activated lymphocyte, or directly with transcription factors such as NF-AT, NF-kB and Erg3, involved in the T-cell activation and regulation of Fas and FasL gene expression, acting as a transcription repressor.
GILZ and regulation of cell death: role of NF-kB
It has recently been reported that the NF-kB complex, which has also been shown to either induce or protect from apoptosis, 67, 90 is important in the promotion of FasL gene expression. 91, 92 We performed experiments to test whether GILZ could modulate NF-kB activity. Shift and competition experiments indicate that GILZ inhibits NF-kB DNA binding, a pre-requisite for its transcription activity and consequent regulation of cell death. Moreover, transfection experiments indicate that GILZ antagonises in vivo the NF-kB transcription promoting activity (Ayroldi et al, submitted for publication). These observations suggest that in some conditions, including differentiation and/or activation state and presence of co-stimulatory signals, GILZ could induce apoptosis by inhibiting the NF-kB activity, which fits in with the well known capability of GCH to either induce or inhibit apoptosis ( Figure  3 ). In fact, inhibition of NF-kB, while it may counter FasL expression and FasL-dependent death, could result in PCD induction when NF-kB acts as a protective factor. 93 The dual effect: a common event of many apoptosis regulators This GCH-induced dual effect (cell death activation and inhibition) is common to many apoptosis modulators. As an example, it has been previously shown that CD2 can either induce or counter lymphocyte apoptosis and similar results have been obtained with IL-1 and IL-2 that can inhibit DEX-or TCR-activated PCD but also predispose T cells to die. 28, 29, 94, 95 In this respect, it has been reported that TNF binding to the TNFR potentially inhibits apoptosis through caspases activation, but also binds Traf-1, Traf-2, RIP and activates NF-kB transcription which suppresses apoptosis by an unknown mechanism. Moreover, it has been shown that TNF can inhibit death in pre-treated cells. 96 Similar results have been obtained with CD27 that can either induce lymphocyte death via Siva, or protect from apoptosis via interaction with Traf-2 and NF-kB activation, or like 4-1BB and OX40, acting as a co-accessory molecule. 82, 83 Moreover, augmented expression of intracellular molecules such as heat shock protein 70 (HSP70) or NF-kB has been associated with either protection and induction of apoptosis. 97 ± 99 All these observations suggest that a number of signals and stimuli can either induce or protect from apoptosis depending on the stage of T-cell differentiation and activation and contemporary presence of other stimuli. Some of these effects also depend on transcription regulation.
Conclusion
T cells are under the control of a number of stimuli which can contribute to maintain naõ Ève cells surviving and to modulate the Ag-driven development of immune response, either by positive selection and clonal expansion or by negative selection which, together with anergy, contribute to acquire tolerance. In particular, Ag-activated negative selection, a transcription-dependent event, 100 is mediated by apoptosis and is responsible for the elimination of autoreactive clones in the thymus and of the peripheral control of the magnitude of an immune response. Ag/TCR interaction may then induce or counter apoptosis, depending on the stage of T-cell activation and the presence of other stimuli that participate T-cell selection through transcription regulation of gene expression. Studies in a number of experimental systems, including GRnegative mice, indicate that GCH can either activate and/or inhibit T lymphocyte death. These effects suggest a role for steroids in the modulation of immune response, by either induction or inhibition of apoptosis, by complex mechanisms that also require transcription regulation of gene expression. The balance between death-inducing and survival signals will contribute to determine the survival or death and the outcome of the T-cell selection.
The knowledge of the molecular mechanisms involved in GCH-mediated PCD modulation could further contribute to better define the therapeutic approaches aimed to obtain cytotoxic or protective effects in normal and transformed lymphocytes.
